Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Bio

Butyrate: forget probiotics, this is why you need a postbiotic

Is this postbiotic the missing link for improved gut health? Nutritionist Louise Pyne investigates

Evening Standard

Weed dispensary plan at old Rainforest Cafe in River North goes up in smoke

Weed dispensary plan at old Rainforest Cafe in River North goes up in smoke

Two lawsuits sought to block the joint venture between Progressive Treatment Solutions LLC and Bio-Pharm for an outlet at 605 N. Clark St.

Chicago Sun-Times

Are These 3 Medical Stocks Worth Buying?

Are These 3 Medical Stocks Worth Buying?

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Nine 'healthy' habits that aren't as good as you think - from chewing gum to exercise

People may be surprised to hear some of the everyday healthy habits which may not be as good for you as previously believed, such as skipping all fatty foods

Nine 'healthy' habits that may be causing damage if overdone

Some things that are often seen as good for your health could be causing more harm than good.

Nine 'healthy habits' that could do more harm than good - including eating too much veg

Other common habits that can actually be detrimental to your health include taking too many supplements, brushing your teeth too much and chewing gum

Green cleaning products company Bio-D opens pick-up point for home city orders

Fulfilment centre addition follows expansion move across Hull for proud B Corp

Birmingham Post

inkl

Read news from The Economist, FT, and more,
with one subscription

Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference

Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:

What's hot in life sciences? Bio International Convention looks at what's next as pandemic recedes

It's no secret that during the COVID-19 pandemic, the global life sciences industry shined. It ramped up development of everything from diagnostic tests to new vaccines — including two based on previously unproven messenger RNA technology —all within months instead of years.

Tribune News Service

Recap: Bio-Rad Laboratories Q1 Earnings

Recap: Bio-Rad Laboratories Q1 Earnings

Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Beyond longevity: The DIY quest to cheat death and stop aging

Beyond longevity: The DIY quest to cheat death and stop aging

Biohackers engage in DIY biology, experimenting on themselves to enhance their brain and body. And many of them see longevity as the ultimate prize.

What Stocks Does 'The Big Short' Investor Michael Burry Own?

What Stocks Does 'The Big Short' Investor Michael Burry Own?

Michael Burry is the founder and former hedge fund manager of now-defunct Scion Capital, most famously known for his massively profitable contrarian investment in the events leading up to the collapse of the real estate market and subsequently the global financial crisis in 2008.

Ethical cleaning products firm Bio-D becomes Hull's first B Corp certified business

Ethical cleaning products firm Bio-D becomes Hull's first B Corp certified business

Bio-D is one of just a handful of B Corp certified businesses in the UK and the first in Hull

Birmingham Post

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100's of premium titles.
One news app.

1 2

People

Queen Elizabeth II

Steve Reitmeister

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Danaher Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

359,110 stories

135,711 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play